Cost-Effectiveness of Drug Therapy for Hypercholesterolaemia
- 1 July 1992
- journal article
- review article
- Published by Springer Nature in PharmacoEconomics
- Vol. 2 (1) , 34-42
- https://doi.org/10.2165/00019053-199202010-00005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older AmericansArchives of internal medicine (1960), 1991
- Cost effectiveness of incremental programmes for lowering serum cholesterol concentration: is individual intervention worth while?BMJ, 1991
- An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reductionThe American Journal of Cardiology, 1991
- Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease.1991
- The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisalJournal Of Hypertension, 1991
- Screening for hypercholesterolemia among Canadians: how much will it cost?1991
- Clinical benefits and cost-effectiveness of lowering serum cholesterol levels: The case of simvastatin and cholestyramine in The NetherlandsThe American Journal of Cardiology, 1990
- Long-term Cost-effectiveness of Various Initial Monotherapies for Mild to Moderate HypertensionJAMA, 1990
- Asymptomatic hypercholesterolemia: a clinical policy review. The Toronto Working Group on Cholesterol Policy.1990
- Cholesterol, Children, and Heart Disease: An Analysis of AlternativesPediatrics, 1981